Distribution of company announcements to the professional platforms, finance portals and syndication of important corporate news to a wide variety of news aggregators and financial news systems.
DSM N.V. (RDSMY) Royal DSM N.V. has repurchased 534,797 of its own shares in the period from 3 July 2008 up to and including 8 July 2008 at an average price of EUR 35.90. This is in accordance with the second phase of the share buyback program, announced on 5 May 2008. The consideration of this repurchase was EUR 19.2 million.
The total number of shares repurchased under the second phase of this program to date is 6,615,000 shares for a total consideration of EUR 250.0 million. As was announced in the press release of 5 May 2008 this concludes the second phase of the share buy-back program. During the remainder of 2008 no further shares will be bought back under this program.
The total program is planned for EUR 750 million. DSM will review the timing of the buy-back of the final EUR 250 million at the beginning of next year.
DSM - the Life Sciences and Materials Sciences Company Royal DSM N.V. creates innovative products and services in Life Sciences and Materials Sciences that contribute to the quality of life. DSM's products and services are used globally in a wide range of markets and applications, supporting a healthier, more sustainable and more enjoyable way of life. End markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrics and electronics, life protection and housing. DSM has annual sales of almost EUR 8.8 billion and employs some 23,000 people worldwide. The company is headquartered in the Netherlands, with locations on five continents. DSM is listed on Euronext Amsterdam. More information: www.dsm.com.
